ArticleSensors (Basel, Switzerland)2022
OCT Retinal and Choroidal Layer Instance Segmentation Using Mask R-CNN.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 27 citations in OpenAlex.
- RetOCTNet: Deep Learning-Based Segmentation of OCT Images Following Retinal Ganglion Cell Injury.Translational vision science & technology · 2025Article
- A comparative study of machine learning models for automated detection and classification of retinal diseases in Ghana.PloS one · 2025Article
- Advancing Ocular Imaging: A Hybrid Attention Mechanism-Based U-Net Model for Precise Segmentation of Sub-Retinal Layers in OCT Images.Bioengineering (Basel, Switzerland) · 2024Article
- SMLS-YOLO: an extremely lightweight pathological myopia instance segmentation method.Frontiers in neuroscience · 2024Article
- Segmentation of measurable images from standard plane of Graf hip ultrasonograms based on Mask Region-Based Convolutional Neural Network.Joint diseases and related surgery · 2023Article
- Biometric Technologies Based on Optical Coherence Tomography.Sensors (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optical coherence tomography (OCT) of the posterior segment of the eye provides high-resolution cross-sectional images that allow visualization of individual layers of the posterior eye tissue (the retina and choroid), facilitating the diagnosis and monitoring of ocular diseases and abnormalities. The manual analysis of retinal OCT images is a time-consuming task; therefore, the development of automatic image analysis methods is important for both research and clinical applications. In recent years, deep learning methods have emerged as an alternative method to perform this segmentation task. A large number of the proposed segmentation methods in the literature focus on the use of encoder-decoder architectures, such as U-Net, while other architectural modalities have not received as much attention. In this study, the application of an instance segmentation method based on region proposal architecture, called the Mask R-CNN, is explored in depth in the context of retinal OCT image segmentation. The importance of adequate hyper-parameter selection is examined, and the performance is compared with commonly used techniques. The Mask R-CNN provides a suitable method for the segmentation of OCT images with low segmentation boundary errors and high Dice coefficients, with segmentation performance comparable with the commonly used U-Net method. The Mask R-CNN has the advantage of a simpler extraction of the boundary positions, especially avoiding the need for a time-consuming graph search method to extract boundaries, which reduces the inference time by 2.5 times compared to U-Net, while segmenting seven retinal layers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.